SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-270139
Filing Date
2019-10-18
Accepted
2019-10-18 17:09:25
Documents
14
Period of Report
2019-10-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d655928d8k.htm   iXBRL 8-K 34821
2 EX-10.1 d655928dex101.htm EX-10.1 13989
  Complete submission text file 0001193125-19-270139.txt   215080

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20191017.xsd EX-101.SCH 4549
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20191017_def.xml EX-101.DEF 13775
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20191017_lab.xml EX-101.LAB 22823
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20191017_pre.xml EX-101.PRE 14744
15 EXTRACTED XBRL INSTANCE DOCUMENT d655928d8k_htm.xml XML 6494
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 191158376
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences